MedTrace Logo

ICU Readmission in Adult Egyptian Patients Undergoing Living Donor Liver Transplant

NCT04067739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 299

Last updated 2022-02-16

No results posted yet for this study

Summary

Liver transplantation is the only definitive treatment for end stage liver disease. Being a major abdominal surgery, may have postoperative complications that require readmission, which may be serious and life threatening. In general, patients who required ICU readmission showed higher morbidity, mortality and prolonged hospital stay compared to those who did not require readmission. We will conduct this retrospective observational study to identify incidence, causes and outcomes of ICU readmission after LDLT

Conditions

  • ICU Readmission

Interventions

OTHER

non interventional study

non interventional study

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2021-03-15
Completion
2021-06-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04067739 on ClinicalTrials.gov